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Previously we showed that the Sendai virus P protein (568 aa) in virus-infected cells and in virions was primarily and
constitutively phosphorylated on serine(s) in a single tryptic phosphopeptide TP1. By two-dimensional thin-layer electrophore-
sis and chromatography analysis of tryptic phosphopeptides of several deletion and point mutants of the P protein, we now
show that the sole phosphorylation site in TP1 is serine249. Interestingly, when serine249 was deleted or mutagenized
alternate potential serine sites were more heavily phosphorylated. A similar effect was observed when the deletion was
very close to serine249 (D208–236). Mutagenesis of proline250 to alanine abrogated phosphorylation at serine249 sug-
gesting that proline250 is essential for the primary phosphorylation of the P protein. Conceivably, serine249 phosphorylation
is mediated by a proline-directed protein kinase. This finding is unusual because a majority of the P proteins from other
negative-strand RNA viruses have been shown to be phosphorylated primarily by casein kinase II. Our results demonstrate
that the P protein has a strong potency to remain phosphorylated. Based on our previous and present results, we suggest
that the phosphorylation sites on P are dependent on the accessibility of phosphatases rather than kinases as all potential
sites are about equally competent for phosphorylation. We propose that phosphorylation is important for maintaining the
structural integrity of the Sendai virus P protein. q 1996 Academic Press, Inc.
Sendai virus, a prototypic paramyxovirus, belongs to it was shown that the 77 amino terminal residues of P
are important both for viral RNA synthesis and for bindingthe order of Mononegavirales. These are enveloped RNA
viruses whose genome is a single strand of RNA with to the cytosolic NP protein (7, 8). Clearly P protein elicits
several functions by virtue of binding to the viral nucleo-negative polarity. The genomic RNA is tightly covered
with the nucleocapsid protein (NP) in a helical conforma- capsid, the NP, and L proteins.
The P protein in all paramyxoviruses is highly phos-tion. Immediately following the entry of viral helical RNP
(nucleocapsid) into the cytoplasm, RNP-associated viral phorylated on a mole-per-mole basis in comparison to
RNA-dependent RNA polymerase transcribes subgeno- other viral proteins. However, the functional significance
mic size mRNAs (1). Two viral proteins, the polymerase- of the P protein phosphorylation is not clear. This in part
associated phosphoprotein (P) and the large protein (L), may stem from the lack of precise information on the
constitute the viral polymerase activity (2, 3). Over the site of phosphorylation in the P protein. Two previous
past two decades, several studies have been carried out attempts identified the phosphorylation sites in the amino
to define structural and functional aspects of the Sendai terminal half of the Sendai virus P protein but yielded
virus P protein. It was demonstrated by employing V8 ambiguous results with regard to their the precise loca-
protease digestion of the Sendai virus nucleocapsids that tion (9, 10). Previous studies have suggested that the
the carboxy terminal region of P bound to the nucleocap- amino terminal region of this protein which putatively
sid (4). This study was later confirmed with the observa- contained the phosphorylation site(s) was not required
tion that the carboxy terminal region contained two non- for viral transcription (11). However, a recent cell-free
contiguous domains which were necessary in its binding transcription study has suggested a transcription en-
to the viral nucleocapsid (5). Another region in the car- hancing role of phosphorylation in respiratory syncytial
boxy terminal portion of the P protein was found to be virus (RSV), another paramyxovirus (12). In evolutionarily
necessary for interaction with the L protein (6). Recently related vesicular stomatitis virus (VSV), cell-free phos-
phorylation of the analogous P protein has similarly been
implicated in enhancing the transcriptional activity of the
1 Present address: USDA-ARS, Sugarcane Research Unit, P.O. Box
viral polymerase (13, 14). However, this role of phosphor-470, Houma, LA 70361.
ylation has been challenged by other investigators (15,2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (312) 226-6020. 16). A recent study showed that the primary phophoryla-
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tion of the VSV P protein with casein kinase II was im- All deletion mutants were phosphorylated only at serine
residues (data not presented). The mutants which lackedportant for multimerization of the P protein (16). Thus,
despite several studies, the role of P protein phosphory- the TPi1 peptide wereD10–316,D215–316,D208–253,
and D238–253, thus locating the position of TPi1 be-lation in both paramyxoviruses and rhabdoviruses re-
mains unclear. As an alternate means for deciphering tween amino acids 238–253 (Fig. 1A). Since the majority
of our mutants were designed to delete precisely one orthe functional role of the Sendai virus P protein phosphor-
ylation, we sought to determine the precise phosphoryla- more tryptic peptides, mutantD238–253 represented the
mutant from which two tryptic peptides with amino acidtion site(s) in the protein from infected cells.
Our recent studies showed that the Sendai virus P sequence n-PLTPATVPGTR/SPLNR-c were deleted.
Since this mutant had only a single serine residue atprotein in virus-infected cells and in purifed virions was
phosphorylated primarily and constitutively on serine res- position 249 missing, we surmised that the primary phos-
phorylation site of the P protein is at a single serineidue(s) in one major tryptic phosphopeptide (TP1) and
that the other viral proteins are not necessary for its residue, serine249.
Previously we reported that the TPi1 contained greaterphosphorylation (18). This suggested that the P protein
is phosphorylated by a cellular kinase or that the P pro- than 80% of 32P counts (18). Consequently, there were
some additional but minor phosphopeptides present intein is an autokinase. Further, our studies showed that
the cell-free phosphorylation sites of the P protein were the two-dimensional (2-D) map. We showed that these
additional phosphopeptides were about equally phos-entirely different from those in virus-infected cells. These
studies indicated that investigations on P phosphoryla- phorylated in the presence of phosphatase PP1 and
PP2A inhibitor, calyculin A (18). To get a better under-tion must be carried out intracellularly for meaningful
results. Now, we have identified the primary site of phos- standing of these minor phosphopeptides, we analyzed
the wildtype P protein from virus-infected and transfectedphorylation in the P protein by expressing its deletion
and point mutants in mammalian cells. Our results show cells containing higher radioactivity and exposed the
thin-layer plates for a longer time (7–10 days) to autora-that the P protein has an strong tendency to remain phos-
phorylated. Disruption of its primary phosphorylation site diographic films. All the phosphopeptides from the P pro-
tein from infected cell were designated as TPi1–TPi11.or of the region surrounding the site causes alternate
potential sites to be more heavily phosphorylated. In total, we could identify 11 phosphopeptides from virus-
infected P protein, one major (TPi1) and 10 minor (TPi2–To identify the location of phosphoserine(s) in the P
protein, we created several deletion mutants spanning TPi11) (Fig. 2A). Interestingly, the wildtype P protein from
transfected cells contained an additional minor phospho-316 amino terminal residues of the protein (Fig. 1A). Due
to the unavailability of an antibody that would recognize peptide designated as TPt1 (Fig. 2B) which was consis-
tently absent from P in virus-infected cells. Since 32Pamino terminal half of the P protein, we could not use
any carboxy terminal deletion mutants in our studies. counts in the minor phosphopeptides were rather low,
the detectibility of these minor peptides varied. There-The mutants were expressed by transfection in CV1 cells
using vaccinia virus/T7 RNA polymerase expression sys- fore, some of the minor peptides are not readily visible
in the photographs. Relative positions of all the P-specifictem (19). To assess the level of P expression and its
phosphorylation, cells were labeled with [35S]Translabel phosphopeptides detected in both infected and
transfected cells are shown in an overlay (Fig. 2C).or [32P]orthophosphate in parallel experiments and P was
immunoprecipitated and analyzed by SDS–PAGE as de- By comparing phosphopeptide maps of all deletion
mutants (Figs. 3A–3F) with that of the wildtype P (Fig.scribed previously by us (18, 20).
Although the level of P protein expression was similar 2B), we localized the sites of the minor peptides in the
P protein (Fig. 4, Table 1). It is revealing to note thatfor all the mutants, the level of phosphorylation varied
widely in different mutants (Figs. 1B and 1C). While mu- the small deletion mutants (D208–253 and D238–253)
which did not contain the primary phosphopeptide TPi1tant D238–253 was phosphorylated as efficiently as the
wildtype P protein, mutants D10–143 and D208–236 were relatively more phosphorylated at the minor phos-
phopeptides, TPi2, TPi3, TPi4, and TPi6 (Figs. 3D andwere about 40–50% more phosphorylated. In mutants
D10–316, D215–316, and D208–253, the level of phos- 3F), as if to compensate for the loss of TPi1. In addition,
both of these mutants contained an additional phospho-phorylation ranged from 20 to 50% compared to the wild-
type P protein (Figs. 1B and 1C). These results created peptide not detected in other maps (shown by asterisk).
On the other hand, in mutantD208–236 which containedproblem in our assigning any specific region of the P
protein to be the site for its primary phosphorylation. TPi1, all those sites and TPi5 were also relatively more
phosphorylated (Fig. 3E). In fact, in this mutant TPi5 isTherefore, to determine the primary phosphorylation site
precisely, we first localized the site of TP1 (renamed as as heavily phosphorylated as TPi1. This is consistent
with the 60% overall more phosphorylation of this mutantTPi1) in P with the use of deletion mutants described
above. Each deletion phosphoprotein was analyzed for protein in comparison to the wildtype protein (Fig. 1C).
Although the relative intensity of minor phosphopeptidesits phosphoamino acid composition and TPi1 presence.
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FIG. 1. Schematic presentation and expression of deletion mutants of the P protein. (A) Deletion mutants were generated by PCR amplification
of the wildtype plasmid using vent polymerase (NEB) as described in detail elsewhere (33, 34). Broken lines represent the deleted region of the
protein. Precise amino acid deletions are given at the right side of each mutant. (B) Expression of deletion mutants in CV1 cells using vaccinia
virus/T7 RNA polymerase system (18, 19). Left panel presents the immunoprecipitated P protein from 35S-labeled cells and the right panel presents
32P-labeled P protein from a parallel experiment. VI and WT are the proteins from virus infected and wildtype P/C gene-transfected cells, respectively.
Band corresponding to each deletion mutant is shown by a solid dot on the right side. Asterisk shows a nonspecific protein that coimmunoprecipitates
with the 35S-labeled P protein. Procedures for metabolic labeling of proteins and their immunoprecipitations have been described previously (18,
20). (C) Relative level of phosphorylation in deletion and point mutants of the P protein. Relative level of 32P incorporation was determined by
comparing 32P incorporation to 35S incorporation from parallel experiments. The level of 35S of mutant D10–316 which lacks two methionine was
adjusted to wildtype for calculation.
varied with each deletion mutant, it is obvious that TPi2 – of the deletion mutants, we surmised that serine249 is
the sole primary phosphorylation site in the P protein. ToTPi6 have a greater potential for phosphorylation than
the other potential sites (TPi7–TPi11). These results sug- directly test this assumption, we mutagenized serine249
to either alanine or aspartate (Fig. 5A). The mutants weregest that deletion of the primary phosphorylation site or
changes in its vicinity cause conformational changes in analyzed for their expression and phosphorylation by la-
beling with [35S]Translabel and [32P]orthophosphate asthe P protein allowing phosphorylation at alternate sites.
Based on the analysis of 2-D phosphopeptide maps described above. The level of expression of the mutant
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FIG. 2. Two-dimensional tryptic phosphopeptide maps of virus-infected P (A), transfected P (B), and a tracing of the all the phosphopeptides
detected (C). Phosphopeptides were analyzed as described previously (18, 35, 36). X and D represent positions of xylene cyanol and e-dinitrophenol–
lysine dye markers, respectively. O is the position of sample origin. Directions of first-dimensional electrophoresis (/ r 0) and second-dimensional
chromatography are shown by arrows. As the minor phosphopeptides contained very low level of radioactivity, they are barely visible in the figure.
proteins was approximately equal to the wildtype P. How- 1). These are the same peptides that were more heavily
phosphorylated in deletion mutants D208–253, D238–ever, the level of phosphorylation of mutant S249A was
about 20% higher than the wildtype P protein (Figs. 1C 253, and D208–236. These results further showed that
whenever the primary site of phosphorylation was abol-and 5B). The level of phosphorylation of mutant S249D
was approximately equal to the wildtype P protein (data ished, certain potential sites were phosphorylated at a
higher level. Interestingly, mutagenesis of serine249 tonot shown). Analysis of the mutant proteins by 2-D phos-
phopeptide maps showed that both mutants lacked TPi1, aspartate to compensate for the loss of phosphoserine
charge did not result in the loss of P protein phosphoryla-but other potential sites, particularly TPi2, TPi3, TPi4, and
TPi6, were phosphorylated at a higher level (Fig 6; Table tion at alternate sites.
FIG. 3. Two-dimensional tryptic phosphopeptide maps of deletion mutants: (A) D10–316, (B) D10–143, (C) D215–316, (D) D208–253, (E) D208–
236, and (F) D238–253. Asterisk presents the novel phosphopeptide detected in mutants D208–253 and D238–253. Other notations are as
described in the legend to Fig. 2.
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FIG. 4. Location of tryptic phosphopeptides of the P protein based on two-dimensional tryptic phosphopeptide maps of the deletion mutants.
Positions of –SP– sequences in the P protein are shown. The bold SP at 249–250 aa sequence is the primary phosphorylation site. Asterisks
denote the phosphopeptides that have a potential for higher phosphorylation in point and deletion mutants.
Several kinases are known to phosphorylate their sub- potential phosphorylation sites. In the presence of the
inhibitor, these sites were as intensely phosphorylatedstrate at specific consensus sequences (21). The only
known consensus phosphorylation sequence present at as the TPi1 (18). Apparently, all the potential sites have
equal capacity for phosphorylation and thus exist inthe P phosphorylation site is –SP–. SP sequence is a
substrate for several proline-directed protein kinases such phosphorylation-competent conformation, but not all
sites are equally dephosphorylated. Therefore, when ser-as cdc/cdk family of cyclin-dependent and mitogen-acti-
vated (MAP) protein kinases (21, 22). To determine whether ine249 or proline250 was mutated, some of the potential
sites, particularly TPi2, TPi3, TPi4, and TPi6, were notproline250 is necessary for the serine249 phosphorylation,
we mutagenized the proline to alanine. On tranfection, the efficiently dephosphorylated. We suggest that following
deletion or point mutagenesis of serine249 or proline250,mutant P protein was expressed at about the wildtype P
level but was phosphorylated at about 50% of the wildtype the conformation of the P protein is altered such that
some of the potential phosphorylation site were not ac-level (Fig. 5B). The two-dimensional phosphopeptide map
revealed that TPi1 was absent and other potential sites, cessible for dephosphorylation. Thus the primary and
the alternate phosphorylations of the P protein are moreparticulary the TPi4 and TPi6, were relatively more phos-
phorylated (Fig. 6C). It appears that mutagenesis of pro- dependent on the accessibility of phosphatases than that
of kinases. It is not clear why the P protein must maintainline250 decreased the overall phosphorylation of the P pro-
tein. This result showed that proline250 is essential for its phosphorylation by using several alternate phosphory-
lation sites. By deletion mutagenesis of the Sendai virusthe serine249 phosphorylation and that possibly a proline-
directed protein kinase is involved in the primary phosphor- P protein, it was demonstrated that the amino termimal
region which putatively contained the phosphorylationylation of the P protein. However, as proline to alanine
mutagenesis could also cause a conformational change site was not important for the binding of P protein to the
nucleocapsid (5). In view of our demonstration of alter-(23), and thus serine249 may not be accessible for phos-
phorylation or may be readily accessible to dephosphoryla- nate phosphorylation sites of the P protein, it is possible
that the P protein used in these studies was not unphos-tion, therefore, the identity of the kinase involved in the
primary phosphorylation of the Sendai virus P protein re- phorylated. Recently, it was observed that deletion of
amino-terminal 78–320 amino acids had no effect on themains to be determined.
Previously, we showed, using phosphatases PP1 and RNA synthesis ability of the P protein (8). Thus the role
of phosphorylation in this protein still remains open.PP2A inhibitor calyculin A, that the P protein has other
TABLE 1
Presence and Relative Level of Phosphorylation of Tryptic Peptides
Sample TRi1 TPi2 TPi3 TPi4 TPi5 TPi6 TPi7 TPi8 TPi9 TPi10 TPi11 TPt1
P-infected /// // // / // / / / / / / 0
P-transfected /// / // // / / / / / / / //
10–316 0 /// 0 0 / 0 0 // / 0 / 0
10–143 /// // // // / / / / / / / /
215 –316 0 // 0 // / // // / / 0 / //
208 –253 00 // // // / // / // / 00 / //
208 –236 /// / // // /// / / / / 0 / /
238 –253 0 // /// // / // / / / 0 / /
S249A 0 // /// /// / // // / / 0 / //
S249D 0 // /// /// / // / / / 0 / //
P250A 0 // // /// / // // / / 0 / //
Note. Sample represents the P protein from infected, wildtype transfected, or from various deletion or point mutant transfected CV1 cells.
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FIG. 5. Schematic presentation of point mutants and their expression in CV1 cells. Point mutants were created by PCR amplification of full-length
wildtype plasmid using a mutagenic primer and a complementary primer (34) or using single-strand DNA (37). (A) Sequence of amino acids from
283 to 254 encompassing the TPi1 phosphopeptide. Presence (/) or absence (0) of TPi1 is indicated at the right side of each of the mutant. (B)
Expression of point mutants in CV1 cells. In parallel experiments, cells were labeled with 35S or 32P and the P protein immunoprecipitated. Notations
are as described in the legend to Fig. 1B.
Serine249 and most of the alternate phosphorylation in the phosphorylation of P proteins with the ultimate
goal to phosphorylate the P protein.sites (except TPi2 and TPi5) are localized in a region of
the P protein that has a very high probability of b-turns It is interesting to note that the P protein is the highest
phosphorylated protein in Sendai virus on a mole-per-as predicted by two different algorithms (24, 25). It was
shown that greater than 90% of phosphates of P in nu- mole basis (9, 29). Moreover, previously it was shown
that the P protein in infected cells occurs primarily in onecleocapsids was susceptible to digestion by bacterial
alkaline phosphatase (9). This finding is consistent if phosphorylated isoform (18, 30), indicating that almost all
the P protein molecules are phophorylated at serine249.phosphates occurred at b-turns. However, there are only
5 –SP– sequence (at 216, 249, 260, 447, and 529) in the However, because greater than 80% of 32P radioactivity
reside on serine249, the stoichiometry of the P proteinP protein (Fig. 4), while we could detect 11 phosphopep-
tides. If all the –SP– sites were phosphorylated by a phosphorylation is most likely in the order of 1.2– 1.5
mole phosphate per mole of P protein. Because the levelproline-directed kinase (PDPK), we suggest that kinases
other than PDPK are also involved in the phosphorylation of phosphorylation of other viral protein is rather low, it
is obvious, therefore, that only a few percent moleculesof the P protein. Recently it was demonstrated that the
P protein of human parainfluenza virus 3 is phosphory- of other protein are phosphorylated.
The Sendai virus V protein which is also encoded inlated by protein kinase C isoform z (26), whereas P pro-
teins of measles virus (27) and RSV (28, 29) have been the P gene has been shown to be phosphorylated (31).
It is interesting to note that the transcriptional editing ofshown to be phosphorylated by casein kinase II. Similarly
VSV P protein is phosphorylated by casein kinase II (17). the P mRNA to generate the V mRNA occurs at nucleotide
1053, and the frame-switching occurs at aa 317 (32).It appears, therefore, that various kinases are involved
FIG. 6. Two-dimensional tryptic phosphopeptide maps of point mutants: (A) Serine249 to alanine, (B) serine249 to aspartate, and (C) proline250
to alanine. All notations have been described in the legend to Fig. 2.
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